Søby, S. (2022) “Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study”, Acta Oncologica, 61(8), pp. 972–978. doi: 10.1080/0284186X.2022.2103387.